Replies to post #18410 on Biotech Values

[io_io]

PTIE.............Praveen:

Well 20% of $500m as a royalty is approx $100m in pure profit - the technology-patent royalties are paid separately by KG.

I think PTIE has less than 50m shares O/S, so that would be eventually $2 per share. Plus the Cash/Milestones.

Plus the PTIE pipeline, which when I looked at before, is not at all empty.

I don't own PTIE, it's a while since I looked at it, but basically I don't understand why the price is stuck in the $8s now - unless the fear is that KG may not close, or will seek better terms due to share-holder pressure.

[DewDiligence]

>Right now I am scratching my head over kerx:-) <

I think a lot of people are.

Based on the clinical data, I think KERX deserves to go down tomorrow. But it won’t surprise me unduly if Weiss spins the results enough to make the stock go up, at least temporarily.

One poster on Yahoo predicts clear sailing to $80 a share, unless the company is acquired sooner. Another poster on SI (of all places) has already accused me of being a market manipulator for posting skeptically about the new data.